Development of Rat Caries-Induced Pulpitis Model for Vital Pulp Therapy.


Journal

Journal of dental research
ISSN: 1544-0591
Titre abrégé: J Dent Res
Pays: United States
ID NLM: 0354343

Informations de publication

Date de publication:
05 2023
Historique:
medline: 1 5 2023
pubmed: 14 3 2023
entrez: 13 3 2023
Statut: ppublish

Résumé

Rodent animal models for vital pulp therapy are commonly used in dental research because their tooth anatomy and cellular processes are similar to the anatomy and processes in humans. However, most studies have been conducted using uninfected sound teeth, which makes it difficult to adequately assess the inflammatory shift after vital pulp therapy. In the present study, we aimed to establish a caries-induced pulpitis model based on the conventional rat caries model and then evaluate inflammatory changes during the wound-healing process after pulp capping in a model of reversible pulpitis induced by carious infection. To establish the caries-induced pulpitis model, the pulpal inflammatory status was investigated at different stages of caries progression by immunostaining targeted to specific inflammatory biomarkers. Immunohistochemical staining revealed that both Toll-like receptor 2 and proliferating cell nuclear antigen were expressed in moderate and severe caries-stimulated pulp, indicating that an immune reaction occurred at both stages of caries progression. M2 macrophages were predominant in moderate caries-stimulated pulp, whereas M1 macrophages were predominant in the severe caries-stimulated pulp. Pulp capping in teeth with moderate caries (i.e., teeth with reversible pulpitis) led to complete tertiary dentin formation within 28 d after treatment. Impaired wound healing was observed in teeth with severe caries (i.e., teeth with irreversible pulpitis). During the wound-healing process in reversible pulpitis after pulp capping, M2 macrophages were predominant at all time points; their proliferative capacity was upregulated in the early stage of wound healing compared with healthy pulp. In conclusion, we successfully established a caries-induced pulpitis model for studies of vital pulp therapy. M2 macrophages have an important role in the early stages of the wound-healing process in reversible pulpitis.

Identifiants

pubmed: 36913545
doi: 10.1177/00220345221150383
pmc: PMC10152557
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

574-582

Références

Front Physiol. 2018 May 01;9:419
pubmed: 29765329
Odontology. 2013 Jan;101(1):9-14
pubmed: 23129523
Aust Dent J. 2007 Mar;52(1 Suppl):S17-31
pubmed: 17546859
Science. 2011 Jun 10;332(6035):1284-8
pubmed: 21566158
Oper Dent. 2009 Sep-Oct;34(5):615-25
pubmed: 19830978
Aust Endod J. 2020 Apr;46(1):154-166
pubmed: 31865629
Stem Cell Res Ther. 2021 Jan 22;12(1):75
pubmed: 33482900
BMC Med Ethics. 2012 Jul 08;13:16
pubmed: 22769234
J Endod. 2017 Jan;43(1):90-95
pubmed: 27866710
Int Endod J. 2012 Jul;45(7):597-613
pubmed: 22329525
Int Endod J. 2022 Mar;55 Suppl 1:14-36
pubmed: 35034368
ILAR J. 2006;47(1):5-14
pubmed: 16391426
Sci Rep. 2022 Mar 25;12(1):5176
pubmed: 35338195
J Dent. 2014 Sep;42(9):1156-70
pubmed: 25008021
J Endod. 2020 Sep;46(9S):S161-S174
pubmed: 32950188
J Clin Periodontol. 2017 Mar;44 Suppl 18:S94-S105
pubmed: 28266116
J Endod. 1981 Feb;7(2):52-60
pubmed: 6938624
Am J Pathol. 2013 Nov;183(5):1352-1363
pubmed: 24091222
Mediators Inflamm. 2015;2015:230251
pubmed: 26538821
Sci Rep. 2020 Nov 19;10(1):20216
pubmed: 33214653
J Dent. 2018 Jun;73:76-90
pubmed: 29660488
Clin Oral Investig. 2018 Nov;22(8):2879-2887
pubmed: 29435662
Aust Dent J. 2007 Mar;52(1 Suppl):S4-16
pubmed: 17546858
BMC Oral Health. 2018 Apr 2;18(1):56
pubmed: 29609575
Int J Mol Sci. 2021 Feb 02;22(3):
pubmed: 33540711
Jpn Dent Sci Rev. 2018 Aug;54(3):105-117
pubmed: 30128058
J Dent Res. 2010 Mar;89(3):219-29
pubmed: 20139336
J Dent Res. 2020 Mar;99(3):329-338
pubmed: 31913775
Int Endod J. 2019 Apr;52(4):504-514
pubmed: 30387178
J Dent. 2019 Jul;86:41-52
pubmed: 31121241
Front Immunol. 2014 Oct 17;5:514
pubmed: 25368618
Lab Anim. 2010 Jan;44(1):1-6
pubmed: 19854755
Int Endod J. 2002 Oct;35(10):829-32
pubmed: 12406376
J Endod. 2007 Jun;33(6):643-51
pubmed: 17509400

Auteurs

H Huang (H)

Department of Restorative Dentistry and Endodontology, Graduate School of Dentistry, Osaka University, Suita-shi, Osaka, Japan.

M Okamoto (M)

Department of Restorative Dentistry and Endodontology, Graduate School of Dentistry, Osaka University, Suita-shi, Osaka, Japan.

M Watanabe (M)

Department of Restorative Dentistry and Endodontology, Graduate School of Dentistry, Osaka University, Suita-shi, Osaka, Japan.

S Matsumoto (S)

Department of Restorative Dentistry and Endodontology, Graduate School of Dentistry, Osaka University, Suita-shi, Osaka, Japan.

K Moriyama (K)

Department of Restorative Dentistry and Endodontology, Graduate School of Dentistry, Osaka University, Suita-shi, Osaka, Japan.

S Komichi (S)

Department of Restorative Dentistry and Endodontology, Graduate School of Dentistry, Osaka University, Suita-shi, Osaka, Japan.

M Ali (M)

Department of Restorative Dentistry, Faculty of Dentistry, University of Khartoum, Khartoum, Sudan.

S Matayoshi (S)

Department of Pediatric Dentistry, Graduate School of Dentistry, Osaka University, Suita-shi, Osaka, Japan.

R Nomura (R)

Department of Pediatric Dentistry, Graduate School of Dentistry, Osaka University, Suita-shi, Osaka, Japan.
Department of Pediatric Dentistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima.

K Nakano (K)

Department of Pediatric Dentistry, Graduate School of Dentistry, Osaka University, Suita-shi, Osaka, Japan.

Y Takahashi (Y)

Department of Restorative Dentistry and Endodontology, Graduate School of Dentistry, Osaka University, Suita-shi, Osaka, Japan.

M Hayashi (M)

Department of Restorative Dentistry and Endodontology, Graduate School of Dentistry, Osaka University, Suita-shi, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH